LeaderMed Group and Combiphar Form Joint Venture on LM-008, a Novel GLP-1 Dual Agonist, Targeting Indonesia's High Diabetes and/or Obesity Prevalence LeaderMed and Combiphar form a joint venture to tackle Indonesia’s diabetes and obesity crisis with LM-008 and UltraSculpt, launching a Phase 3 trial.

Global Vegetable (HPMC) Capsule Market Size Envisioned to Surpass $1,162 Million by 2030, Growing at 9.85% CAGR | Sowing Seeds of Prosperity Houston, TX, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Vegetable (HPMC) Capsule Market By Type (HPMC With Gelling Agent And HPMC Without...